Methods involving MS4A12 and agents targeting MS4A12 for therapy, diagnosis and testing

Details for Australian Patent Application No. 2009235746 (hide)

Owner Ganymed Pharmaceuticals AG Johannes Gutenberg-Universitat Mainz

Inventors Tureci, Ozlem; Sahin, Ugur; Koslowski, Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2009235746

PCT Pub. Number WO2009/124670

Priority 08007109.5 10.04.08 EP

Filing date 30 March 2009

Wipo publication date 15 October 2009

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/124670 Priority application(s): WO2009/124670

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009235761-Arrangement of a bellow on a guide mandrel of a disc brake

2009235737-Process of polymerization in emulsion of 1-alkenes and vinyl esters with high conversion and their use